Clinical Trials List
2013-11-01 - 2020-09-30
Phase III
Terminated4
ICD-10D07.5
Carcinoma in situ of prostate
ICD-9233.4
Carcinoma in situ of prostate
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chao-Hsiang Chang Division of Urology
- Chi-Ping Huang Division of Urology
- Chi-Rei Yang Division of Urology
- 謝德鈞 Division of Nuclear Medicine
- Wen-Chi Chen Division of Urology
- Chin-Chung Yeh Division of Urology
- Wei-Ching Lin Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- - - Division of Urology
- - - Division of Urology
- Yeong-Shiau Pu Division of Urology
- CHUNG-HSIN CHEN Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 余家政 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chuan-Shu Chen Division of Urology
- Shian-Shiang Wang Division of Urology
- 熊小澐 Division of Radiology
- Cheng-Kuang Yang Division of Urology
- Jian-Ri Li Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
1,150 participants
